Comparative Real-World Effectiveness of Rituximab vs Cladribine in Relapsing-Remitting Multiple Sclerosis
In the changing landscape of relapsing-remitting multiple sclerosis (RRMS), decisions around aggressive treatments rest on clinical trial data…